Pharmacist prescribing made headlines this week… with some stakeholders for, and some as usual against
The Pharmacy Board revealed its position on pharmacist prescribing, saying that under Health Practitioner Regulation National Law, there were “no regulatory barriers in place for pharmacists to be able to prescribe… within a collaborative healthcare environment, via a structured prescribing arrangement or under supervision”. The PSA and Guild welcomed the statement… as did the Australian Medical Association, in the latter case because the Board did not back autonomous prescribing by pharmacists.
The AMA also released 10 new minimum standards for prescribing, which are aimed at keeping it out of the hands of pharmacists.
Meanwhile, in its submission to the Royal Commission into Aged Care Quality and Safety, the Guild rejected a proposal to embed pharmacists independent of community pharmacy, saying this would lead to duplication and fragmentation of care.
NSW MP Tim Crakanthorp called for greater transparency around pharmacists and other health workers found to have engaged in professional misconduct and other misbehaviour, following the suspension of one pharmacist’s registration after he bashed three people and failed to report the incidents to regulators.
Thanks to NDARC‘s latest latest Drug Trends report, we discovered that the use of cocaine, ketamine and amyl nitrate have all gone up in the past year, while non-prescribed use of opioids such as morphine, codeine and oxycodone has come down.
We learned that Chemist Warehouse has partnered with MedAdvisor for the promotion, recording and delivery of all its health programs… and the discount giant is also reportedly set to open its first bricks-and-mortar store in China.
Mark Kinsela has been appointed as new CEO of the PSA, and been congratulated on the new position by pharmacy stakeholder groups. And Brianne Lowe was named Pharmacy Assistant of the Year out of an outstanding field of finalists. Congratulations from AJP to all!